Clinical Trials · NCT05469126
A Drug Interaction Study of Clarithromycin and LY3502970 in Healthy Participants
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Eli Lilly and Company
- Enrollment
- 26
- Start date
- Aug 2022
- Locations
- 1 site, Singapore
- Primary endpoint
- Pharmacokinetics (PK): Area Under the Concentration Versus Time Curve (AUC) From Time Zero to Infinity AUC(0-∞) of LY3502970